Direct activation of purified Go-type GTP binding protein by tricyclic antidepressants. 1992

H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
Division of Mental Disorder Research, National Institute of Neuroscience, NCNP, Tokyo, Japan.

A growing body of evidence suggests that tricyclic antidepressant agents (TCAs) interact with GTP binding proteins (G proteins). We have investigated if TCAs directly alter the function of the purified Go protein which is specifically expressed in neuronal tissue. Several TCAs markedly enhanced the GTPase activity of Go protein in a pertussis toxin-susceptible manner, whereas MAO-inhibitor and anxiolytic agent did not. This enhancing effect of TCAs on Go function may be due to an increase in the GDP-GTP exchange reaction occurring on Go. Thus, it is very likely that TCAs can modify various signal transduction by directly interacting with G proteins in brain cells.

UI MeSH Term Description Entries
D010566 Virulence Factors, Bordetella A set of BACTERIAL ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor. Bordetella Virulence Factors,Agglutinogen 2, Bordetella Pertussis,Bordetella Virulence Determinant,LFP-Hemagglutinin,LP-HA,Leukocytosis-Promoting Factor Hemagglutinin,Lymphocytosis-Promoting Factor-Hemagglutinin,Pertussis Agglutinins,Agglutinins, Pertussis,Determinant, Bordetella Virulence,Factor Hemagglutinin, Leukocytosis-Promoting,Factor-Hemagglutinin, Lymphocytosis-Promoting,Factors, Bordetella Virulence,Hemagglutinin, Leukocytosis-Promoting Factor,LFP Hemagglutinin,LP HA,Leukocytosis Promoting Factor Hemagglutinin,Lymphocytosis Promoting Factor Hemagglutinin,Virulence Determinant, Bordetella
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D006160 Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP,Triphosphate, Guanosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D016244 Guanosine 5'-O-(3-Thiotriphosphate) Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes. GTP gamma S,Guanosine 5'-(gamma-S)Triphosphate,gamma-Thio-GTP,GTPgammaS,Guanosine 5'-(3-O-Thio)Triphosphate,gamma S, GTP,gamma Thio GTP
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory
D037342 Pertussis Toxin One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity. IAP Pertussis Toxin,Islet-Activating Protein,Pertussigen,Histamine-Sensitizing Factor,Islets-Activating Protein,Lymphocytosis-Promoting Factor,Histamine Sensitizing Factor,Islet Activating Protein,Islets Activating Protein,Lymphocytosis Promoting Factor,Pertussis Toxin, IAP,Toxin, IAP Pertussis,Toxin, Pertussis

Related Publications

H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
January 1980, Postgraduate medical journal,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
March 1992, Biochemical and biophysical research communications,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
June 1994, Biochemistry,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
January 1987, Nature,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
August 1994, Laboratory investigation; a journal of technical methods and pathology,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
January 2001, Journal of biomedical science,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
January 1989, Cellular signalling,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
July 1987, Biochemical and biophysical research communications,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
October 2008, Neuropharmacology,
H Yamamoto, and U Tomita, and M Mikuni, and I Kobayashi, and A Kagaya, and T Katada, and M Ui, and K Takahashi
February 1995, The EMBO journal,
Copied contents to your clipboard!